Cureus . A Case Series of Myocarditis Related to the COVID-19 Vaccine

[tetano]

Cureus


. 2022 Oct 4;14(10):e29892.
doi: 10.7759/cureus.29892. eCollection 2022 Oct.
A Case Series of Myocarditis Related to the COVID-19 Vaccine


Hayfa O Ahmed[SUP] 1 [/SUP], Mawada M Ahmed[SUP] 1 [/SUP], Omer Elrasheid[SUP] 1 [/SUP]



Affiliations

• PMID: 36348838
• PMCID: PMC9631103
• DOI: 10.7759/cureus.29892

Abstract

Perimyocarditis related to the coronavirus disease 2019 (COVID-19) vaccine is one of the rare adverse events that emerged in April 2021 and then the number of cases commensurably increased as the number of vaccinated people rose. This is a case series of myocarditis/pericarditis related to the messenger RNA (mRNA) COVID-19 vaccine in which we identified four cases with different presentations and outcomes. A short-term follow-up period of five months revealed a full recovery of three cases within one to 12 weeks and persistent left ventricular systolic dysfunction in the fourth case which will require further follow-up to assess long-term outcomes.

Keywords: covid-19; myocarditis; pericarditis; perimyocarditis; vaccine.